Dictionary of Nutraceuticals and Functional Foods - 1st Edition Optimized DOCX Download
Dictionary of Nutraceuticals and Functional Foods - 1st Edition Optimized DOCX Download
Visit the link below to download the full version of this book:
https://medipdf.com/product/dictionary-of-nutraceuticals-and-functional-foods-1s
t-edition/
Dictionary of
Nutraceuticals
and Functional
Foods
N. A. Michael Eskin
Snait Tamir
A CRC title, part of the Taylor & Francis imprint, a member of the
Taylor & Francis Group, the academic division of T&F Informa plc.
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742
© 2005 by Taylor & Francis Group, LLC
CRC Press is an imprint of Taylor & Francis Group, an Informa business
This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been
made to publish reliable data and information, but the author and publisher cannot assume responsibility for the valid-
ity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright
holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this
form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may
rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or uti-
lized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopy-
ing, microfilming, and recording, or in any information storage or retrieval system, without written permission from the
publishers.
For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://
www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923,
978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For
organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged.
Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for
identification and explanation without intent to infringe.
Visit the Taylor & Francis Web site at
http://www.taylorandfrancis.com
and the CRC Press Web site at
http://www.crcpress.com
Dedication
1
2 ACETYL-L-CARNITINE
disease, and cerebrovascular accidents, as well potential in the therapeutic treatment of Parkin-
as aging. Seidman and coworkers (2000) exam- son’s disease.
A ined the ability of two mitochondrial metabo- Tomassini et al. (2003) found that acetyl-L-
lites, including acetyl-L-carnitine, to enhance carnitine was well-tolerated as an alternative to
mitochondrial function and reverse age-related the drug amantadine for the treatment of fatigue
processes in experimental rats. Acetyl-L-car- in multiple-sclerosis patients. A recent review
nitine was found to delay the decline in mito- by Ilias et al. (2004) pointed to the potential of
acetyl-L-carnitine for treating complications
H3C associated with HIV infection and antiretroviral
+ O
therapy. However, the data obtained so far were
N
based on small, uncontrolled clinical trials and
H3C
CH3 require further investigation.
OH
H3C O
References
Acetyl-L-carnitine. (From Ilias et al., Mitochon- Biagiotti, G. and Cavallini, G., Acetyl-L-carnitine vs
drion. 4:163–168, 2004. With permission.) tamoxifen in the oral treatment of Peyronie’s disease:
a preliminary report, B.J.U. Int., 88(1):63–67, 2001.
chondrial function by reducing age-associated Dolezal, V. and Tucek, S., Utilization of citrate, ace-
deterioration in auditory sensitivity and improv- tylcarnitine and carnitine palmityltransferase in the
ing cochlear function. Kopke and colleagues transport of fatty acyl groups across mitochondrial
(2002) also found that acetyl-L-carnitine membranes, J. Neurochem., 36:1323–1330, 1981.
reduced noise-induced hearing loss in animals
Ilias, I., Manoli, I., Blackman, M.R., Gold, P.W., and
due to cochlear injury from oxidative stress.
Alesci, S., L-Carnitine and acetyl-L-carnitine in the
Turpeinen et al. (2000) showed acetyl-L-car-
treatment of complications associated with HIV
nitine prevented loss of myocardial sympathetic infection and antiretroviral therapy, Mitochondrion.
nervous function in patients with diabetes. Kaur 4:163–168, 2004.
and coworkers (2001) demonstrated new anti-
aging effects of acetyl-L-carnitine by its ability Kaur, J., Sharma, D., and Singh, R., Acetyl-L-car-
to enhance glutathione S-transferase and multi- nitine enhances Na(+), K(+)-ATP-ase glutathione-S-
transferase and multiple unit activity and reduces
ple-unit activity and reduce lipid peroxidation
lipid peroxidation and lipofuscin concentration in
and lipofuscin levels in the brain regions of aged rat brain regions, Neurosci. Lett., 301:1–4, 2001.
aged rats. Biagiotti and Cavallini (2001)
reported acetyl-L-carnitine was a far more Kopke, R.D., Coleman, J.K., Liu, J., Campbell, K.C.,
effective and safer alternative to tamoxifen in and Riffenburgh, R.H., Candidate’s thesis: Enhanc-
the treatment of Peyronie’s disease. A recent ing intrinsic cochlear stress defenses to reduce noise-
induced hearing loss, Laryngoscope, 112(9):1515–
study by Mazzio et al. (2003) showed acetyl-
1532, 2002.
L-carnitine prevented neurological damage in
mouse brain neuroblastoma cells by 1-methyl- Loots, D.T., Mienie, L.J., Bergh, J.J., and Van der-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP+), Schyf, C.J., Acetyl-L-carnitine prevents total body
a cogent Parkinson-causing agent. This benefi- hydroxyl free radical and uric acid production
cial effect may be due to its ability to sustain induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropy-
neuronal energy supplies in the absence of oxy- ridine (MPTP) in the rat, Life Sci., 75:1243–1253,
2004.
gen or when there is a malfunction of mitochon-
drial oxygen utilization, typical of Parkinson’s Mazzio, E., Yoon, K.J., and Soliman, K.F.A., Acetyl-
disease. Recent studies by Loots et al. (2004) L-carnitine protection against 1-methyl-4-phenylpy-
suggested acetyl-L-carnitine may prevent ridinium toxicity in neuroblastoma cells, Biochem.
MPTP+ toxicity by denying cation access to the Pharmacol., 66:297–306, 2003.
inner mitochondrial membrane, thereby atten- Seidman, M.D., Khan, M.J., Bai, U., Shirwany, N.,
uating its ability to produce radical-oxygen spe- and Quirk, W.S., Biologic activity of mitochondrial
cies via the electron-transport chain. These metabolites on aging and age-related hearing loss,
results suggest acetyl-L-carnitine may have Am. J. Otol., 21(2):161–167, 2000.
ACRIDONE ALKALOIDS 3
O OH
O OH O OH
6
1 2 R1
N
R1
O
A
R4
R5 5 N 4 3 R2 N O
R3 R2 R2
R4 CH3 R3 OH CH3 R1
R1 R2 R3 R4 R5 R1 R2 R3 R4 R1 R2
1 H OH H H H 9 H H H H 16 OCH3 H
2 OCH3 OCH3 H OH H 10 H CH3 H H 17 H prenyl
3 H OCH3 H OH OCH3 11 H H OCH3 OH
4 H OCH3 OCH3 OH H 12 prenyl H H H
5 H OCH3 OCH3 OCH3 OH 13 prenyl H OH H
6 H OH prenyl H H 14 prenyl CH3 H H
7 H OCH3 prenyl H H 15 prenyl CH3 OH H
8 geranyl OH H OH H
18 prenyl OH prenyl H H
prenyl = geranyl =
SCHEME A.1 Structures of acridone alkaloids tested for inhibition of TPA-induced EBV-EA activation. (From
Itoigawa et al., Cancer Lett., 193:133–138, 2003. With permission.)
Tomassini, V., Pozzilli, C., Onesti, E., Pasqualetti, P., when tested in a short-term, in vitro assay of
Marinelli, F., Pisani, A., and Fieschi, C., Comparison 12-O-tetradecanoylphorbol-13-acetate (TPA)-
of the effects of acetyl-L-carnitine and amantadine induced Epstein–Barr virus early antigen (EBV-
for the treatment of fatigue in multiple sclerosis: EA) activation in Raji cells. The prenylated
Results of a pilot, randomised, double-blind, cross-
acridone alkaloids included glycocitrin-II (6),
over study, J. Neurol. Sci., 218:103–108, 2004.
O-methylglycocirine-II (7), severifoline (12),
Turpeinen, A.K., Kuikka, J.T., Vanninen, E., Yang, and ataphyllinine (13). The importance of the
J., and Uusitupa, M.I., Long-term effect of acetyl-L- prenyl group was confirmed with the synthetic
carnitine on myocardial 1231-MIBG uptake in diprenylated acridone, 1,3-dihydroxy-10-
patients with diabetes, Clin. Auton. Res., 10(1):13– methyl-2,4-diprenylacridone (18). Using an in
16, 2000. vivo, two-stage mouse skin carcinogenesis
model, it reduced the percentage of tumor-bear-
ing mice to 73 percent after 10 weeks (Figure
A.1), and the number of papillomas by approx-
Acridone alkaloids Acridone alkaloids have
imately 48 percent after 20 weeks (Figure
been isolated from a number of plant sources,
A.1B), compared to the nonprenylated acri-
including citrus plants (family Rutacea). Some
dones, 1,3-dihydroxy-10-methylacridone (1)
of them have been shown to exhibit cytotoxic,
and glycofilinine (5).
antiviral, and antimalarial properties (Kawaii et
al., 1999; Yamamoto et al., 1989; Queener et References
al., 1991). A screening test showed that acri- Itoigawa, M., Ito, C., Wu, T-S., Enjo, F., Tokuda, H.,
done alkaloids from citrus plants exhibited the Nishino, H., and Furukawa, H., Cancer chemopre-
most potent inhibition of 12-O-tetrade- ventive activity of acridone alkaloids on
canoylphorbol-13-acetate (TPA)-induced Epstein–Barr virus activation and two-stage mouse
Epstein–Barr virus early antigen (EBV-EA) skin carcinogenesis, Cancer Lett., 193:133–138,
activation (Takemura et al., 1995). Further stud- 2003.
ies by Itoigawa and coworkers (2003) isolated Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., Yano,
17 acridone alkaloids from Rutaceous plants. M., Takemura, Y., Ju-ichi, M., Ito, C., and Furukawa
Their structures are shown in Scheme A.1. Of H., The antiproliferative effect of acridone alkaloids
these, the prenylated acridones were found to on several cancer cell lines, J. Nat. Prod.,
be the most potent cancer protective agents 62:587–589, 1999.
4 ADLAY
100 10
A
Papillomas bearers (%)
80 8
Papillomas/Mouse
60 6
40 4
20 2
0 0
5 10 15 20 5 10 15 20
Weeks after promotion Weeks after promotion
(a) (b)
FIGURE A.1 Inhibitory effects of acridone alkaloids on DMBA-TPA mouse skin carcinogenesis. Tumor
formation in all mice was initiated with DMBA (dimethylbenz[α]anthracene) (390 nmol) and promoted with
TPA (1.7 nmol) twice weekly, starting one week after initiation. (a) Percentage of mice with papillomas. (b)
Average number of papillomas per mouse: ●, control TPA alone; o, TPA + 85 nmol of 1,3-dihydroxy-10-
methyl-2.4-diprenylacridone (18); ∆, TPA + 85 nmol of 1,3-dihydroxy-10-methylacridone (1); ▫ , TPA + 85
nmol of glycofolinine (5). After 20 weeks of promotion, a difference in the number of papillomas per mouse
between the groups treated with acridones and the control was evident (p < 0.05). (From Itoigawa et al.,
Cancer Lett., 193:133–138, 2003. With permission.)
Queener, S.F., Fujioka, H., Nishiyama, Y., Furikawa, showed dehulled adlay had a significant effect
H., Bartlett, M.S., and Smith, J.W., In vitro activities on the growth of intestinal bacteria in rats. Ani-
of acridone alkaloids against Pneumocystis carnii, mals fed adlay had normal, healthy walls with
Antimicrob. Agents. Chemother., 33:6–9, 1991. no pathogenic signs. In addition, there were
Takemura, Y., Ju-Ichi, J., Ito, C., Furukawa, H., and higher concentrations of short-chain fatty acids
Tokuda, H., Studies on the inhibitory effects of some in the GI tracts. One of these, butyric acid, was
acridone alkaloids on Epstein–Barr virus activation, shown to inhibit the growth of colonic tumors
Planta Med., 61:366–368, 1995. (Smith and German, 1995). Kuo and coworkers
(2001) found that methanolic extracts of adlay
Yamamoto, N., Furukawa, H., Ito, Y., Yoshida, S.,
hulls exhibited multiple antioxidant properties
Maeno, K., and Nishiyama, Y., Anti-herpesvirus
activity of citrusinine-1, a new acridone alkaloid, and and induced apoptosis in human histolytic lym-
related compounds, Antiviral Res., 12:21–36, 1989. phoma monocytic cells. The antitumor proper-
ties of adlay were further demonstrated by
Chiang et al. (2000b) by its inhibition of sar-
coma-180 tumors in mice. A methanolic extract
Adlay Adlay (Coix lachryma-jobi L.), a grass of adlay was subsequently shown by Chang et
crop grown in China, is used as an herbal med- al. (2003) to be antiproliferative on A549 lung
icine and a food. A number of bioactive sub- cancer cells in mice by inducing cell cycle
stances isolated from different parts of adlay arrest and apoptosis. Shih et al. (2004) recently
were shown to exhibit anti-inflammatory, anti- found that a diet containing 20 percent dehulled
tumor, and hypoglycemic activities. Early stud- adlay suppressed the early events in the devel-
ies by Ukita and Tanimura (1961) and Tanimura opment of cancer and not the formation of
(1961) showed the active component in adlay tumors in azoxymethane-induced colon car-
that inhibited the growth of Ehrlich ascites sar- cinogenesis in rats.
coma was coixenolide. A number of benzox- Kuo and coworkers (2002) identified the
azines isolated from adlay seeds were later antioxidants in a 1-butanol extract of adlay hulls
found to have anti-inflammatory activity exhibiting strong, radical-scavenging activity as
(Nagao et al., 1985). Chiang et al. (2000a) coniferyl alcohol, syringic acid, ferulic acid,
ADLAY 5
2.5
2.0
Control
10% dehulled adlay
20% dehulled adlay
A
50% dehulled adlay
1.5
Elisa unit *
1.0 *
*
0.5
0.0
FIGURE A.2 Effects of different dosages of dehulled adlay on OVA-specific IgE levels in serum of mice
consuming the test diets for six weeks and then intraperitoneally immunized with OVA plus alum. (From Hsu
et al., J. Agric. Food Chem., 51:3763–3769, 2003. With permission.)
syringaresinol, 4-ketopinoresinol, and a new Hsu, H.-Y., Lin, B.-F., Lin, J.-Y., Kuo, C.C., and
lignan, mayuenolids. Hsu et al. (2003) showed Chiang, W., Suppression of allergic reactions by
that oral administration of several fractions dehulled adlay in association with the balance of
obtained from dehulled adlay modulated Th1/Th2 cell responses, J. Agric. Food Chem.,
51:3763–3769, 2003.
Th1/Th2 cytokine production in cultured sple-
nocytes obtained from ovalbumin (OVA)- Kim, S.O., Yun, S.-J., Jung, B., Lee, E.H., Hahm, D.-
immunized male BALB/c mice. This caused Y., Shim, I., and Lee, H.-J. Hypolipidemic effects of
suppression of IgE biosynthesis (Figure A.2), crude extract of adlay seed (Coix lachrymajobi var:
which suggested it could be used to alleviate mayuen) in obesity rat fed high fat diet: Relation of
allergic symptoms. TNF-α and leptin mRNA expressions and serum
lipid levels, Life Sci., 75:1391–1404, 2004.
A crude adlay-seed extract was shown by
Kim and coworkers (2004) to exert hypolipi- Kuo, C.-C., Shih, M.-C., Kuo, Y.-H., and Chiang, W.,
demic effects in obese rats maintained on a Antagonism of free-radical-induced damage of adlay
high-fat diet. The adlay extract modulated seed and its antiproliferative effect in human his-
expression of both leptin and TNF-α, reducing tolytic lymphoma U937 monocytic cells, J. Agric.
body weight, food intake, fat size, adipose tis- Food Chem., 49:1564–1570, 2001.
sue mass, and serum hyperlipidemia. Adlay Kuo, C.-C., Chiang, W., Liu, G.-P., Chien, Y.-L.,
appears to have therapeutic potential for treat- Chang, J.-Y., Lee, C.K., Lo, J.M., Huang, S.L., Shih,
ing obesity. M.C., and Kuo, Y.H., 2,2′-Diphenyl-1-picrylhydrazyl
radical-scavenging active components from Adlay
References (Coix lachryma-jobi L. var. ma-yuen Stapf) hulls, J.
Agric. Food Chem., 50:5850–5855, 2002.
Chang, H.-C., Huang, Y.-C., and Hung, W.-C., Anti-
proliferative and chemopreventive effects of adlay Nagao, T., Otsuka, H., Kohda, H., Sato, T., and
seed on lung cancer in vitro and in vivo, J. Agric. Yamasaki, K., Benzoxazinone from Coix lachryma-
Food Chem., 51:3656–3660, 2003. jobi var. ma-yuen, Phytochemistry, 24:2959–2962,
1985.
Chiang, W., Cheng, C., Chiang, M., and Chung,
K.-T., Effects of dehulled adlay on the culture count Shih, C.-K., Chiang, W., and Kua, M.-L., Effects of
of some microbiota and their metabolism in the gas- adlay on azoxymethane-induced colon carcinogene-
trointestinal tract of rats, J. Agric. Food Chem., sis in rats, Food Chem. Toxicol., 42:1339–1347,
48:829–832, 2000a. 2004.
Chiang, W., Shyu, M.-L., Su, J.-P., and Pangm V.F., Smith, M.L. and German, J.B., Molecular and
Evaluation of the accessory anti-tumor effect of adlay genetic effects of dietary derived butyric acid, Food
processing food, J. Health Sci., 2:113–122, 2000b. Technol., 49:87–90, 1995.
6 ADZUKI BEANS
Ye, X.Y. and Ng, T.B., Purification of angularin, a Swanston-Flatt, S.K., Day, C., Bailey, C.J., and Flatt,
novel antifungal peptide from adzuki beans, J. Pep- P.R., Evaluation of traditional plant treatments for
tide Sci., 8:101–106, 2002. diabetes: Studies in streptozocotin diabetic mice,
Acta Diabetol. Lat., 26:51–55, 1989.
Yoshiki, Y., Kim, J.H., Okubo, K., Nagoya, L., Sak-
abe, T., and Tamura, N., A saponin in conjugated
with 2,3-dihydro-2,5-dihydroxy-6-methyl-4H-
pyran-2-ene from Dolichos lablab, Phytochemistry,
38:229–231, 1995.
Ajoene Ajoene (E,Z)-4,5,9-trithiadodeca-1,6,11-
triene 9 oxide), an organic trisulphur compound
Yoshiki,Y., Kinumi, M., Kahara, T., and Okubo, K., originally isolated from garlic, is formed from
Chemiluminescence of soybean saponins in the pres- the spontaneous degradation of allicin.
ence of active oxygen species, Plant Sci.,
116:125–129, 1996. CH2 CHCH2SSCH CHCH2S(O)CH2CH CH2
Yoshiki, Y., Okuba, K., and Igarashi, K., In Food
Factors for Cancer Prevention, H. Ogihashi, T. Ajoene. (From MacDonald and Langler, Biochem.
Osawa, J. Terao, S. Watanabe, and T. Yoshikawa, Biophys. Res. Comm., 273:421–424, 2000. With per-
Eds., Tokyo, Spinger, Tokyo, 1997, p. 313. mission.)
AJOENE 7
The possible pharmacological role of garlic effect was activation of caspase-3, a prerequi-
in the prevention and treatment of cancers was site for apoptosis. A recent study by Ledezma
attributed to the presence of ajoene. Rendu and et al. (2004) showed the cytotoxic effect of A
coworkers (1989) reported ajoene was the anti- ajoene on murine melanoma B16F10 cells was
platelet compound in garlic responsible for also associated with activation of caspase-3 and
inhibiting platelet aggregation. Later work by subsequent apoptosis.
Apitz et al. (1992) showed the antiplatelet activ- Using the water-maze test, Yamada et al.
ity of ajoene prevented thrombus formation (2004) recently found that only Z-ajoene, and
induced by vascular damage. Urbina and not alliin or diallyl disulfide, reduced acetylcho-
coworkers (1993) also found ajoene to be a linesterase (AChE) activity in the brain of sco-
potent antiplatelet compound capable of inhib- polamine-induced, memory-impaired mice.
iting both epimastogotes and amastigotes of Excessive production of AChE leads to a defi-
Trypanoso-ma cruiz, the causative agent for ciency of acetyl choline, resulting in a loss of
Chaga’s disease. Dirsch et al. (1998) reported memory and cognitive-impairment characteris-
ajoene-induced apoptosis in human promylelo-
tic of Alzheimer’s disease. Improvements
leukemic cells but not in periphereal mononu-
observed following treatments with Z-ajoene
clear cells of healthy donors. The mechanism
suggest it could be used to treat this disease.
proposed was that ajoene stimulated peroxide
formation in the leukemic cells and activated Gallwitz and coworkers (1999) also showed
NF-κΒ. The antitumor properties of ajoene that the antiparasitic and cytostatic properties
were demonstrated in vivo by Li et al. (2002ab, of ajoene were due to its effect on key enzymes
2003), who showed it inhibited proliferation involved in antioxidant thiol metabolism.
and induced apoptosis in several cancer-cell Ajoene was previously found to inhibit HMG-
lines by activation of NF-κΒ and caspase-8. CoA reductase, a key enzyme in cholesterol
Hassan (2004) suggested that inhibition of pro- biosynthesis, as well as in the later steps of the
liferation and induction of apoptosis by ajoene mevalonate pathway in rat hepatocytes and
was associated with blocking the G2/M phase HepG2 cells (Gebhardt et al., 1994). In addition
of the cell cycle and activation of caspase-3 by to being a precursor of cholesterol, mevalonate
ajoene, making it a new antileukemia agent for is also a precursor of other nonsteroid iso-
acute myeloid leukemia therapy (AML). prenoids (e.g., farnesyl and geranylgeranyl) that
Ajoene could be effective in elderly AML attach themselves to proteins and are crucial for
patients with poor tolerance to conventional cell proliferation (Grunler et al., 1994). Ferri
chemotherapies. For example, Table A.1 shows and coworkers (2003) reported, for the first
the effect of ajoene with traditional drugs, cyt- time, inhibition of protein prenylation and cell
arabine and fludarabine, on bcl-2 expression proliferation by ajoene in the smooth-muscle
and caspase-3 activation in human-resistant cells cultured from the aorta of Sprague–Daw-
myeloid leukemia cells. The most significant ley rats.
TABLE A.1
Bcl-2 Expression and Caspase-3 Activation in CD34 + CD7 + Human Resistant
Myeloid Leukemia Cells Following Treatment with Cytarabine or Fludarabine
in Presence or Absence of Ajoene
Bcl-2 (U/million cells) Activated caspase-3 (pg/million cells)
No ajoene With ajoene P No ajoene With ajoene P
2.50
2.00
Granada
? A
1.50
? Turin
?
1.00
0.50
0.00
0 2 4 6 8 10 12 14
Alcohol (ml)
FIGURE A.3 Association between geometric mean 8-oxodGuo × 104 levels and mean alcohol consumption
among nonsmoking, premenopausal women between the four centers. (From Bianchi et al., Carcinogenesis,
22:885–890, 2001. With permission.)
120
A 100
*
**
**
***
60 ***
***
40
20
0
Control
Alfalfa
Soy
Acerola
Alfalfa + Acerola
Soy + Acerola
FIGURE A.4 LDL- formation mediated by cells after addition of 100 µg/mL LDL protein. Cells were
incubated under standard conditions (control) and preincubated with acerola, soy, soy and acerola, alfalfa, and
alfalfa and acerola, extracts for five days, with male rabbit aortic endothelial cells. (From Hwang et al., J.
Agric. Food Chem., 49:308–314, 2001. With permission.)